Eton Pharmaceuticals (ETON) Net Cash Flow Growth (1y) (2019 - 2025)
Eton Pharmaceuticals (ETON) Net Cash Flow Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -117.27% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -167.84% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -290.21% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 270.63% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -367.42% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -7.60% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 272.00% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.76 Bn | 1.73 Bn | 25.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -109.93% |
| Sep 30, 2025 | 357.42% |
| Jun 30, 2025 | 666.03% |
| Mar 31, 2025 | 152.48% |
| Dec 31, 2024 | -680.79% |
| Sep 30, 2024 | 409.33% |
| Jun 30, 2024 | -84.85% |
| Mar 31, 2024 | -196.37% |
| Dec 31, 2023 | -123.30% |
| Sep 30, 2023 | 113.74% |
| Jun 30, 2023 | 277.44% |
| Mar 31, 2023 | -294.05% |
| Dec 31, 2022 | 135.25% |
| Sep 30, 2022 | -18.59% |
| Jun 30, 2022 | 22,812.50% |
| Mar 31, 2022 | -78.44% |
| Dec 31, 2021 | -159.46% |
| Sep 30, 2021 | -5.28% |
| Jun 30, 2021 | 99.61% |
| Mar 31, 2021 | 1,319.33% |